Remote video URL
Your peers have not rated this talk yet.
1-minute watch | Talk 7 of 7

EHA: Managing R/R adult ALL in the CAR T era

Summary and close

Prof. Max Topp
University Hospital Würzburg, Würzburg, Germany

Prof. Max Topp, University Hospital Würzburg, Würzburg, Germany, summarises the key takeaways from case studies discussed on CAR T treatment aproaches in R/R adult ALL

Read more

Talks in this series

Interested in this topic?

Suggested for you

Explore suggested content tailored to your role within the CAR T-cell therapy journey

Job code: IHQ-UNB-4903 Date of preparation: October 2023
Job code: IHQ-UNB-4971 Date of preparation: October 2023

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In Great Britain and Northern Ireland, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.